Examination of the effect of topical Rebamipide after the vitreous surgery in dry eye patients

Examination of the effect of topical Rebamipide after the vitreous surgery in dry eye patients - Effect of Rebamipide after the vitreous surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010457

Enrollment

Registered

2013-06-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye patients underwent vitreous surgery

Interventions

Topical Rebamipide No therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dry eye patient Post-non sutuered vitrectomy

Exclusion criteria

Exclusion criteria: Ocular surface disease other than dry eye Pregnant or lactating patient Rebamipide allergy

Design outcomes

Primary

Measure	Time frame
Fluorescein corneo-conjunctival staining score	—

Secondary

Measure	Time frame
Photophobia, Misty vision, Asthenopia, Feeling of dryness, Foreign-body sensation, Eye pain	—

Countries

Japan

Contacts

Public ContactMasafumi Uematsu

Nagasaki University Graduate School of Biomedical Sciences Department of Ophtalmology

uematsu-ngs@umin.ac.jp095-819-7345

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026